Case studies of three pregnant smokers and their use of nicotine replacement therapy
- PMID: 15967546
- DOI: 10.1016/j.midw.2004.12.008
Case studies of three pregnant smokers and their use of nicotine replacement therapy
Abstract
Objective: To examine the barriers encountered by pregnant women who attempt to stop smoking by highlighting three women who used nicotine patches.
Design: A randomised-controlled trial of nicotine-replacement therapy (NRT) in the form of patches to test its acceptability for pregnant women. Ethics approval was granted despite NRT being contraindicated in Australia for pregnant women and having a low safety rating (category D) (Australian Drug Evaluation Committee, 1999). Salivary cotinine levels were used to assess nicotine exposure and provide some indicator of NRT safety. All participants were given pregnancy-specific cessation counselling, and the 20 women in the treatment arm were offered nicotine patches (15 mg/16 hr), with the option of weaning to lower strength patches if desired.
Setting: The Women's and Children's Hospital, Adelaide, a public tertiary teaching hospital in South Australia, with almost 4000 births annually.
Sample: 40 'high-risk' pregnant smokers who expressed interest in stopping smoking.
Findings: As has been found in the general population, 'quit' rates with NRT use were low. Only three of the participants in this study, who became abstinent with patch use during pregnancy, were still abstinent at birth. The circumstances of two of these women, and a third woman who used patches to 'control' her smoking despite researcher advice, are detailed here. Only one of the two women 'abstinent at delivery' was still abstinent 3 months after birth, the last contact point of the study.
Key conclusions and implications for practice: Although health providers intuitively regard pregnancy as an appropriate time for women to stop smoking, the stressors during pregnancy seem to militate against cessation. This study does not indicate that use of NRT will provide an easier solution. It may be more fruitful to institute a concerted lifestyle approach with both the woman and her partner (or significant household members), and continue this support and education postnatally if cessation has not been achieved. Health professionals should also support better-targeted public health campaigns and tobacco-control initiatives generally, because, undoubtedly, the social environment is a major determinant of initiation and continuation of smoking.
Similar articles
-
A randomised-controlled pilot study using nicotine patches with pregnant women.Addict Behav. 2006 Apr;31(4):641-8. doi: 10.1016/j.addbeh.2005.05.042. Epub 2005 Jun 27. Addict Behav. 2006. PMID: 15985339 Clinical Trial.
-
'Breathe': the stop smoking service for pregnant women in Glasgow.Midwifery. 2010 Jun;26(3):e1-e13. doi: 10.1016/j.midw.2008.05.005. Epub 2008 Aug 8. Midwifery. 2010. PMID: 18692285
-
Exploring the views of women on using nicotine replacement therapy in pregnancy.Midwifery. 2010 Aug;26(4):401-6. doi: 10.1016/j.midw.2008.11.001. Epub 2009 Jan 29. Midwifery. 2010. PMID: 19185398
-
[Smoking reduction and temporary abstinence: new approaches for smoking cessation].J Mal Vasc. 2003 Dec;28(5):293-300. J Mal Vasc. 2003. PMID: 14978435 Review. French.
-
Women's use of nicotine replacement therapy in pregnancy-a structured review of the literature.Midwifery. 2010 Jun;26(3):304-10. doi: 10.1016/j.midw.2008.08.002. Epub 2008 Oct 15. Midwifery. 2010. PMID: 18926608 Review.
Cited by
-
Interventions for promoting smoking cessation during pregnancy.Cochrane Database Syst Rev. 2009 Jul 8;(3):CD001055. doi: 10.1002/14651858.CD001055.pub3. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2013 Oct 23;(10):CD001055. doi: 10.1002/14651858.CD001055.pub4. PMID: 19588322 Free PMC article. Updated.
-
Does the use of nicotine replacement therapy during pregnancy affect pregnancy outcomes?Matern Child Health J. 2009 Jul;13(4):497-504. doi: 10.1007/s10995-008-0361-1. Epub 2008 May 14. Matern Child Health J. 2009. PMID: 18478321
-
Factors influencing the uptake and use of nicotine replacement therapy and e-cigarettes in pregnant women who smoke: a qualitative evidence synthesis.Cochrane Database Syst Rev. 2020 May 22;5(5):CD013629. doi: 10.1002/14651858.CD013629. Cochrane Database Syst Rev. 2020. PMID: 32441810 Free PMC article.
-
Pharmacological interventions for promoting smoking cessation during pregnancy.Cochrane Database Syst Rev. 2020 Mar 4;3(3):CD010078. doi: 10.1002/14651858.CD010078.pub3. Cochrane Database Syst Rev. 2020. PMID: 32129504 Free PMC article.
-
Psychosocial interventions for supporting women to stop smoking in pregnancy.Cochrane Database Syst Rev. 2013 Oct 23;10(10):CD001055. doi: 10.1002/14651858.CD001055.pub4. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2017 Feb 14;2:CD001055. doi: 10.1002/14651858.CD001055.pub5. PMID: 24154953 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials